Fli-1, an Ets-related transcription factor, regulates erythropoietin- induced erythroid proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during differentiation

Molecular and Cellular Biology

Volumn 19, Issue 6, 1999, Pages 4452-4464

  Tamir, Ami ^a   Howard, Jeff ^a   Higgins, Rachel R ^a   Li, You Jun ^a   Berger, Lloyd ^a   Zacksenhaus, Eldad ^a   Reis, Marciano ^b   Ben David, Yaacov ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FLI 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; ERYTHROPOIESIS; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

EID: 0032974230     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.6.4452     Document Type: Article

References (80)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Ben-David, Y., E. G. Giddens, K. Letwin, and A. Bernstein. 1991. Erythroleukemia induction by Friend murinc leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908-918.
3. Ben-David, Y., V. R. Prideaux, V. Chow, S. Benchimol, and A. Bernstein. 1988. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene 3:179-185.
4. Bergh, G., M. Ehinger, T. Olofsson, B. Baldetorp, E. Johnsson, H. Brycke, G. Lindgren, I. Olsson, and U. Gullberg. 1997. Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood 89:2938-2950.
5. Chabot, B., D. Stephenson, V. M. Chapman, P. Besmer, and A. Bernstein. 1988. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88-89.
6. Chow, V., Y. Ben-David, A. Bernstein, S. Benchimol, and M. Mowat. 1987. Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J. Virol. 61:2777-2781.
7. Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van de Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328-330.
8. Clarke, M. F., J. F. Kukowska-Latallo, E. Westin, M. Smith, and E. V. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8:884-892.
9. Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, K. Joubert, P. de Jong, G. Rouleau, A. Aurias, and G. Thomas. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
10. Dmitrovsky, E., W. M. Kuehl, G. F. Hollis, I. R. Kirsh, T. P. Bender, and S. Segal. 1986. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukemia cell line. Nature 322:748-750.
11. Dolznig, H., P. Bartunek, K. Nasmyth, E. W. Mullner, and H. Beug. 1995. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ. 6:1341-1352.
12. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonucleases fragments to high specific activity. Anal. Biochem. 132:6-13.
13. Friend, C., W. Seher, J. G. Holland, and T. Sato. 1971. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA 68:378-382.
14. Gill, R. M., P. A. Hamel, J. Zhe, E. Zacksenhaus, B. L. Gallie, and R. A. Phillips. 1994. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ. 5:467-474.
15. Gobel, M. G., F. Moreau-Gachelin, D. Ray, P. Tambourin, A. Tavitian, M. J. Klemsz, S. C. McKercher, C. Van Beveren, and R. A. Maki. 1990. The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell 61:1165-1166.
16. 15a. Gross-Bellard, M., P. Oudet, and P. Chambon. 1973. Isolation of high-molecular-weight DNA from mammalian cells. Eur. J. Biochem. 36:32-38.
17. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580-1584.
18. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoter EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431-3438.
19. Hicks, G. G., and M. Mowat. 1988. Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemia cell line. J. Virol. 62:4752-4755.
20. Howard, J. C., Y. Ung, D. Adachi, and Y. Ben-David. 1996. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias. Cell Growth Differ. 7:1651-1660.
21. Howard, J. C., L. Berger, M. R. Bani, R. Hawley, and Y. Ben-David. 1996. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene 12:1405-1415.
22. Howard, J. C., S. Yousefi, G. Cheong, A. Bernstein, and Y. Ben-David. 1993. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene 8:2721-2729.
23. Hu, N., M. L. Gulley, J. T. Kung, and E. Y. H. P. Lee. 1997. Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis. Cancer Res. 57:4123-4129.
24. Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
25. Jacobs-Helber, S. M., K. Penta, Z. Sun, A. Lawson, and S. T. Sawyer. 1997. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J. Biol. Chem. 272:6850-6853.
26. Jiang, Z., E. Zacksenhaus, B. L. Gallie, and R. A. Phillips. 1997. The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797.
27. Kabat, D. 1990. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148:1-42.
28. Kieran, M. W., A. C. Perkins, S. H. Orkin, and L. I. Zon. 1996. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 93:9126-9131.
29. Kiyokawa, H., V. M. Richon, R. A. Rifkind, and P. A. Marks. 1994. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol. Cell. Biol. 14:7195-7203.
30. Klinken, S. P., N. A. Nicola, and G. R. Johnson. 1988. In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin. Proc. Natl. Acad. Sci. USA 85: 8506-8510.
31. Koury, M. J., and M. Bondurant. 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381.
32. Kwiatkowski, B. A., L. S. Bastian, T. R. Bauer, S. Tsai, A. G. Zielinska-Kwiatkowska, and D. D. Hickstein. 1998. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J. Biol. Chem. 273:17525-17530.
33. Lachman, H. M., K. S. Hatton, A. I. Skoultchi, and C. L. Schildkraut. 1985. c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment. Proc. Natl. Acad. Sci. USA 82:5323-5327.
34. Lachman, H. M., and A. I. Skoultchi. 1984. Expression of c-myc changes during differentiation of mouse erythroleukemia cells. Nature 310:592-594.
35. LaMarco, K., C. C. Thompson, B. P. Byers, E. M. Walton, and S. L. McKnight. 1991. Identification of Ets- and notch-related subunits in GA binding protein. Science 253:789-792.
36. Lee, E. Y.-H. P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288-294.
37. Liboi, E., M. Carroll, A. D. D'Andrea, and B. Mathey-Prevot. 1993. Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc. Natl. Acad. Sci. USA 90:11351-11355.
38. Lin, C. S., S. K. Lim, V. D'Agati, and F. Costantini. 1996. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev. 10:154-164.
39. Lu, S. J., S. Rowan, M. R. Bani, and Y. Ben-David. 1994. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. USA 91:8398-8402.
40. Maandag, E. C., M. van der Valk, M. Vlaar, C. Feltkamp, J. O'Brien, M. van Roon, N. van der Lugt, A. Berns, and H. te Riele. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13:4260-4268.
41. Mager, D., T. W. Mak, and A. Bernstein. 1980. Friend leukemia virus-transformed cells, unlike normal stem cells, form spleen colonies in Sl/Sld mice. Nature 288:592-594.
42. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
43. Mao, X., S. Miesfeldt, H. Yang, J. M. Leiden, and C. B. Thompson. 1994. The FLI-1 and chimeric ES-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269:16216-16222.
44. Marks, P. A., V. M. Richon, H. Kiyokawa, and R. A. Rifkind. 1994. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc. Natl. Acad. Sci. USA 91:10251-10254.
45. May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Lunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. 1993. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90:5752-5756.
46. McNiece, I. K., K. E. Langley, and K. M. Zsebo. 1991. Recombinant human stem cell factor synergises with GM-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hematol. 19: 226-231.
47. Mélet, F., B. Motro, D. J. Rossi, L. Zhang, and A. Berinstein. 1996. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol. Cell. Biol. 16:2708-2715.
48. Migliaccio, G., A. R. Migliaccio, M. L. Druzin, P. J. Giardina, K. M. Zsebo, and J. W. Adamson. 1991. Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J. Cell. Physiol. 148:503-509.
49. Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
50. Moreau-Gachelin, F., A. Tavitian, and P. Tambourin. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature 331:277-280.
51. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature 314:633-636.
52. Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. J. Scott, and S. S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677-689.
53. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend erythroleukemia: relation to dominant transforming alleles. Mol. Cell. Biol. 10:3307-3313.
54. Muta, K. 1995. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 86:572-580.
55. Nocka, K., S. Majumder, B. Chabot, P. Ray, M. Cervone, A. Bernstein, and P. Besmer. 1989. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3:816-826.
56. Orlando, V., and R. Paro. 1993. Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell 75:1187-1198.
57. Pawson, T., and A. Bernstein. 1990. Receptor tyrosine kinases: genetic evidence for their role in Drosophila and mouse development. Trends Genet. 6:350-356.
58. Perkins, A. C., A. H. Sharpe, and S. H. Orkin. 1995. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375:318-322.
59. Pevny, L., M. C. Simon, E. Robertson, W. H. Klein, S. F. Tsai, V. D'Agati, S. H. Orkin, and F. Costantini. 1991. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257-250.
60. Prochownik, E. V., and J. Kukowska. 1986. Deregulation expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322:848-850.
61. Quang, C. T., O. Wessely, M. Pironin, H. Beug, and J. Ghysdael. 1997. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. EMBO J. 16:5639-5653.
62. Rao, V. N., T. Ohno, D. D. Prasad, G. Bhattacharya, and E. S. Reddy. 1993. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene 8:2167-2173.
63. Savoysky, E., T. Mizuno, Y. Sowa, H. Watanabe, J. Sawada, H. Nomura, Y. Ohsugi, H. Handa, and T. Sakai. 1994. The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family. Oncogene 9:1839-1846.
64. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
65. Shibuya, T., and T. Mak. 1983. Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E). Proc. Natl. Acad. Sci. USA 80:3721-3725.
66. Shivdasani, R. A., and S. H. Orkin. 1996. The transcriptional control of hematopoiesis. Blood 87:4025-4039.
67. Solomon, M. J., P. L. Larsen, and A. Varshavsky. 1988. Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell 53:937-947.
68. Sowa, Y., Y. Shiio, T. Fujita, T. Matsumoto, Y. Okuyama, D. Kato, J. Inoue, J. Sawada, M. Goto, H. Watanabe, H. Handa, and T. Sakai. 1997. Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1. Cancer Res. 57:3145-3148.
69. Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
70. Thompson, C. C., T. A. Brown, and S. L. McKnight 1991. Convergence of Ets- and notch-related structure motifs in a heteromeric DNA binding complex. Science 253:762-768.
71. Todokoro, J., R. J. Watson, H. Higo, H. Amanuma, S. Kuramochi, H. Yanagisawa, and Y. Ikawa. 1988. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc. Natl. Acad. Sci. USA 85:8900-8904.
72. Tsai, S. F., D. I. Martin, L. I. Zon, A. D. D'Andrea, G. G. Wong, and S. H. Orkin. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339:446-451.
73. Weber, B. I., E. H. Westin, and M. F. Clarke. 1990. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA. Science 249:1291-1293.
74. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
75. Williams, B. O., E. M. Schmitt, L. Remington, R. T. Bronson, D. M. Albert, R. A. Weinberg, and T. Jacks. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13:4251-4259.
76. Wu, H., U. Klingmuller, A. Acurio, J. G. Hsiao, and H. F. Lodish. 1997. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc. Natl. Acad. Sci. USA 94: 1806-1810.
77. Wu, H., X. Liu, R. Jaenisch, and H. F. Lodish. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67.
78. Youssoufian, H., G. Longmore, D. Neumann, A. Yoshimura, and H. F. Lodish. 1993. Structure, function, and activation of the erythropoietin receptor. Blood 81:2223-2236.
79. Zacksenhaus, E., M. Gill, R. A. Phillips, and B. L. Gallie. 1993. Molecular cloning and characterization of the mouse RB1 promoter. Oncogene 8:2343-2351.
80. Zhang, L., V. Lemarchandel, P. Romeo, Y. Ben-David, and A. Bernstein. 1993. The Fli-1 proto-oncogene involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other ets family members. Oncogene 8:1621-1630.